Allan L. Goldstein, Director at REGENERX BIOPHARMACEUTICALS INC (RGRX), bought 125,000 shares at $0.20 ($25K) on 2021-06-30, disclosed to the SEC on 2021-07-06.
Open-market purchase of $25k RGRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.